KR102523776B1 - Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability - Google Patents
Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability Download PDFInfo
- Publication number
- KR102523776B1 KR102523776B1 KR1020220122122A KR20220122122A KR102523776B1 KR 102523776 B1 KR102523776 B1 KR 102523776B1 KR 1020220122122 A KR1020220122122 A KR 1020220122122A KR 20220122122 A KR20220122122 A KR 20220122122A KR 102523776 B1 KR102523776 B1 KR 102523776B1
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- idcc
- composition
- bifidobacterium lactis
- functional food
- Prior art date
Links
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 title claims abstract description 28
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 title claims abstract description 21
- 235000019155 vitamin A Nutrition 0.000 title claims abstract description 21
- 239000011719 vitamin A Substances 0.000 title claims abstract description 21
- 229940045997 vitamin a Drugs 0.000 title claims abstract description 21
- OGQHCUYSWDOIMP-UHFFFAOYSA-N 7-(diethylamino)-n-[2-[(2-iodoacetyl)amino]ethyl]-2-oxochromene-3-carboxamide Chemical compound C1=C(C(=O)NCCNC(=O)CI)C(=O)OC2=CC(N(CC)CC)=CC=C21 OGQHCUYSWDOIMP-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 title claims abstract description 19
- 229940009289 bifidobacterium lactis Drugs 0.000 title claims abstract description 19
- 235000013376 functional food Nutrition 0.000 title claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 210000000481 breast Anatomy 0.000 claims abstract description 3
- 235000013305 food Nutrition 0.000 claims description 21
- 210000003608 fece Anatomy 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 description 11
- 229930003231 vitamin Natural products 0.000 description 11
- 235000013343 vitamin Nutrition 0.000 description 11
- 239000011782 vitamin Substances 0.000 description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 235000013361 beverage Nutrition 0.000 description 9
- 239000006041 probiotic Substances 0.000 description 8
- 235000018291 probiotics Nutrition 0.000 description 8
- 229960003471 retinol Drugs 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 235000019169 all-trans-retinol Nutrition 0.000 description 5
- 239000011717 all-trans-retinol Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000015203 fruit juice Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- -1 pH adjusters Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000005471 regulation of growth hormone secretion Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/702—Vitamin A
-
- A23Y2300/49—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 비타민 A 생성능이 우수한 비피도박테리움 락티스 IDCC 4301을 포함하는 조성물 및 건강기능식품에 관한 것이다. The present invention relates to a composition and health functional food containing Bifidobacterium lactis IDCC 4301 having excellent vitamin A production ability.
비타민은 체내 신진대사에 필수적인 미량의 유기물질로, 신체의 발육, 일상 활동 및 건강 유지를 위한 영양소이다. 비타민은 크게 지용성 비타민과 수용성 비타민으로 분류가 된다. 지용성 비타민은 체내 지방조직 또는 간에 축적되어 장시간 저장이 가능한 반면, 수용성 비타민은 체내에 저장되지 않고 소변을 통해 배출되기 때문에 꾸준한 섭취가 필요하다. Vitamins are trace amounts of organic substances essential for metabolism in the body and are nutrients for the body's development, daily activities, and maintenance of health. Vitamins are broadly classified into fat-soluble vitamins and water-soluble vitamins. Fat-soluble vitamins accumulate in the body's fat tissue or liver and can be stored for a long time, whereas water-soluble vitamins are not stored in the body and are excreted through urine, so a steady intake is necessary.
비타민 A(레티놀, retinol)는 동물성 식품에 주로 함유되어 있으며, 전구체인 베타카로틴 형태로 식물성 식품을 통해서도 섭취할 수 있다. 비타민 A는 눈 건강 유지뿐만 아니라 피부, 모발, 치아 건강에도 도움을 준다. 더불어 비타민 A는 항체 증진을 통한 면역 기능 향상, 신경계 조절, 성장 호르몬 분비 조절을 통한 생장 발육에도 관여한다고 알려져 있다.Vitamin A (retinol, retinol) is mainly contained in animal foods, and can also be consumed through plant foods in the form of beta-carotene, a precursor. Vitamin A helps maintain eye health, as well as skin, hair and teeth health. In addition, vitamin A is known to be involved in growth and development through the improvement of immune function through the promotion of antibodies, the regulation of the nervous system, and the regulation of growth hormone secretion.
반면, 비타민 A 결핍 시 시각 기능이 저하되어 야맹증을 유발할 수 있으며, 세균 감염 취약에 따른 면역 기능 약화, 성장 지연, 피부 건조 등이 나타날 수 있다. 이에 따라, 식품 또는 영양제를 통해 비타민 A를 꾸준히 보충해주어야 한다.On the other hand, vitamin A deficiency can cause night blindness due to reduced visual function, weakened immune function due to vulnerability to bacterial infection, delayed growth, and dry skin. Accordingly, it is necessary to steadily supplement vitamin A through food or nutritional supplements.
본 발명은 비타민 A 생성능이 우수한 비피도박테리움 락티스 IDCC 4301을 포함하는 조성물 및 건강기능식품을 제공하는 것을 목적으로 한다. An object of the present invention is to provide a composition and health functional food containing Bifidobacterium lactis IDCC 4301 having excellent vitamin A production ability.
본 발명의 목적은 비타민 A 생성 기능을 가지는 조성물에 있어서, 비피도박테리움 락티스 IDCC 4301[기탁번호: ATCC BAA-2848]을 포함하는 것에 의해 달성된다.The object of the present invention is achieved by including Bifidobacterium lactis IDCC 4301 [accession number: ATCC BAA-2848] in a composition having a vitamin A producing function.
상기 비피도박테리움 락티스 IDCC 4301은 모유를 먹인 유아의 대변로부터 분리된 것일 수 있다.The Bifidobacterium lactis IDCC 4301 may be isolated from feces of breastfed infants.
상기 본 발명의 목적은 상기 조성물을 0.1 내지 50중량% 포함하는 비타민 A 생성 기능을 가지는 식품에 의해 달성될 수 있다.The object of the present invention can be achieved by a food having a vitamin A producing function containing 0.1 to 50% by weight of the composition.
상기 본 발명의 목적은 상기 조성물을 0.1 내지 50중량% 포함하는 비타민 A 생성 기능을 가지는 건강기능식품에 의해 달성될 수 있다.The object of the present invention can be achieved by a health functional food having a function of producing vitamin A containing 0.1 to 50% by weight of the composition.
본 발명에 따르면 비타민 A 생성능이 우수한 비피도박테리움 락티스 IDCC 4301을 포함하는 조성물 및 건강기능식품이 제공된다. According to the present invention, a composition and health functional food containing Bifidobacterium lactis IDCC 4301 having excellent vitamin A producing ability are provided.
도 1은 표준물질인 비타민 A의 검량선을 보여주는 그래프이며,
도 2는 유산균 종류에 따른 비타민 A 생산량을 나타낸 것이다.1 is a graph showing a calibration curve of vitamin A, which is a standard substance;
Figure 2 shows the vitamin A production according to the type of lactic acid bacteria.
이하 도면을 참조하여 본 발명을 더욱 상세히 설명한다.The present invention will be described in more detail with reference to the following drawings.
첨부된 도면은 본 발명의 기술적 사상을 더욱 구체적으로 설명하기 위하여 도시한 일 예에 불과하므로 본 발명의 사상이 첨부된 도면에 한정되는 것은 아니다. 또한 첨부된 도면은 각 구성요소 간의 관계를 설명하기 위해 크기와 간격 등이 실제와 달리 과장되어 있을 수 있다.Since the accompanying drawings are only examples shown to explain the technical spirit of the present invention in more detail, the spirit of the present invention is not limited to the accompanying drawings. In addition, in the accompanying drawings, sizes and intervals may be exaggerated unlike actual ones in order to explain the relationship between each component.
본 발명은 유산균을 포함하는 비타민 A 생성능을 가진 조성물에 관한 것이다.The present invention relates to a composition containing lactic acid bacteria and capable of producing vitamin A.
본 발명의 유산균은 비피도박테리움 락티스 IDCC 4301[기탁번호: ATCC BAA-2848]을 포함한다.The lactic acid bacteria of the present invention include Bifidobacterium lactis IDCC 4301 [accession number: ATCC BAA-2848].
조성물에서 비피도박테리움 락티스 IDCC 4301은 1중량% 내지 100중량%, 10중량% 내지 90중량% 또는 1중량% 내지 10중량%일 수 있다.Bifidobacterium lactis IDCC 4301 in the composition may be 1% to 100%, 10% to 90% or 1% to 10% by weight.
본 발명은 비타민 A 생성능이 있는 프로바이오틱스를 포함하는 식품 조성물에 관한 것으로, 비피도박테리움 락티스 IDCC 4301[기탁번호: ATCC BAA-2848]을 포함한다.The present invention relates to a food composition containing probiotics capable of producing vitamin A, including Bifidobacterium lactis IDCC 4301 [Accession No.: ATCC BAA-2848].
비피도박테리움 락티스 IDCC 4301은 모유를 먹인 유아의 대변으로부터 분리되었으며, 식품 조성물 내지 건강기능식품 조성물은 비피도박테리움 락티스 IDCC 4301 생균을 0.1억 내지 1000억 또는 1억 내지 100억 CFU/g을 포함할 수 있다.Bifidobacterium lactis IDCC 4301 was isolated from feces of breast-fed infants, and the food composition or health functional food composition contains 0.1 billion to 100 billion or 100 to 100 billion CFU/ may contain g.
본 발명은 비타민 A 생성능이 있는 프로바이오틱스를 포함하는 건강기능식품에 관한 것으로, 비피도박테리움 락티스 IDCC 4301[기탁번호: ATCC BAA-2848]을 유효성분으로 포함한다.The present invention relates to a health functional food containing probiotics capable of producing vitamin A, and contains Bifidobacterium lactis IDCC 4301 [accession number: ATCC BAA-2848] as an active ingredient.
본 발명의 조성물은 비피도박테리움 락티스 IDCC 4301외의 다른 유산균을 포함할 수 있다.The composition of the present invention may contain lactic acid bacteria other than Bifidobacterium lactis IDCC 4301.
본 발명의 식품 조성물은 기능성 식품(functional food), 영양 보조제(nutritional supplement), 건강식품(health food) 및 식품 첨가제(food additives) 등의 모든 형태의 식품에 대한 조성물을 포함한다. 상기 유형의 식품 조성물은 당업계에 공지된 통상적인 방법에 따라 다양한 형태로 제조할 수 있다. 예를 들면, 건강식품으로는 유산균이 함유된 껌, 비타민 복합체, 차, 주스 및 드링크 형태로 제조할 수 있으며, 비피도박테리움 락티스 IDCC 4301을 유효성분으로 하는 식품 조성물을 과립화, 캡슐화 또는 분말화하여 섭취할 수 있다. The food composition of the present invention includes compositions for all types of food, such as functional food, nutritional supplements, health food, and food additives. Food compositions of this type can be prepared in various forms according to conventional methods known in the art. For example, as a health food, it can be prepared in the form of gum, vitamin complex, tea, juice and drink containing lactic acid bacteria, and a food composition containing Bifidobacterium lactis IDCC 4301 as an active ingredient can be granulated, encapsulated or It can be powdered and ingested.
본 발명의 기능성 식품 조성물은 식품 제조 시에 통상적으로 첨가되는 성분을 포함할 수 있으며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함할 수 있다. 예컨대, 드링크제로 제조되는 경우에는 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 대추 추출액, 감초 추출액 등을 추가로 포함시킬 수 있다.The functional food composition of the present invention may include components commonly added during food preparation, and may include, for example, proteins, carbohydrates, fats, nutrients, and seasonings. For example, when prepared as a drink, citric acid, high fructose corn syrup, sugar, glucose, acetic acid, malic acid, fruit juice, jujube extract, licorice extract, and the like may be further included.
식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 천연 과일쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 추출물을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다.Food compositions include various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and enhancers (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, organic acids, It may contain a protective colloidal thickener, a pH adjusting agent, a stabilizer, a preservative, glycerin, alcohol, a carbonating agent used in carbonated beverages, and the like. In addition, it may contain extracts for the production of natural fruit juice, fruit juice beverages and vegetable beverages. These components may be used independently or in combination.
다른 예로, 식품 조성물의 제형은 산제, 과립제, 환, 정제, 캡슐제의 형태뿐만 아니라 일반 식품 또는 음료의 형태 어느 것이나 가능하다.As another example, the formulation of the food composition may be in the form of powders, granules, pills, tablets, capsules, as well as general food or beverage forms.
식품의 종류에는 특별히 제한은 없고, 식품의 예로는 육류, 소세지, 빵, 쵸콜렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함할 수 있다.The type of food is not particularly limited, and examples of food include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea, There are drinks, alcoholic beverages, vitamin complexes, and the like, and may include all foods in a conventional sense.
일반적으로, 식품 또는 음료의 제조시에 비피도박테리움 락티스 IDCC 4301의 사용량은 0.1 내지 50중량%, 0.1 내지 20중량% 또는 0.1 내지 10중량% 포함될 수 있다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있다.In general, when preparing food or beverage, the amount of Bifidobacterium lactis IDCC 4301 used may be 0.1 to 50% by weight, 0.1 to 20% by weight, or 0.1 to 10% by weight. However, in the case of long-term intake for the purpose of health and hygiene or health control, the amount may be less than the above range.
일 구체예에 따른 식품 조성물 중 음료는 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가성분으로 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜일 수 있다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. Among the food compositions according to one embodiment, the beverage may contain various flavoring agents or natural carbohydrates as additional ingredients, like conventional beverages. The aforementioned natural carbohydrates may be monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as thaumatin and stevia extract, or synthetic sweeteners such as saccharin and aspartame may be used.
상기 외에 일 구체예에 따른 식품 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제를 함유할 수 있다. 그 밖에 본 발명의 식품 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다.In addition to the above, the food composition according to one embodiment includes various nutrients, vitamins, electrolytes, flavors, colorants, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin , alcohol, carbonation agents used in carbonated beverages. In addition, the food composition of the present invention may contain fruit flesh for preparing natural fruit juice, fruit juice beverages and vegetable beverages. These components may be used independently or in combination.
이하 실험예를 통해 본 발명을 상세히 설명한다.The present invention will be described in detail through experimental examples below.
[실시예 1] 프로바이오틱스 섭취를 가상한 장모사배지에서 프로바이오틱스 배양 [Example 1] Cultivation of probiotics in long-haired medium simulating intake of probiotics
프로바이오틱스 배양을 위해 표 1에서 제시한 성분이 함유된 장모사 배지를 제조한 뒤 121℃, 15분 동안 멸균하였다. 그 후, 플레이트에 배양된 프로바이오틱스 단일 콜로니는 장모사 액체배지에 1일 동안 혐기적으로 37℃ 조건에서 배양하였고, 바실러스 서브틸리스와 바실러스 코아글란스는 호기적인 조건에서 각각 43℃, 45℃로 배양하였다. 배양액을 4℃, 6,000 rpm 조건에서 원심분리하여 상등액을 회수하였고, 농축기를 사용하여 10배 농축시켰다. 마지막으로, 0.45 ㎛ 크기의 필터를 사용하여 상등액을 여과한 뒤 분석시료를 준비하였다. For probiotics culture, a long hair medium containing the ingredients shown in Table 1 was prepared and then sterilized at 121° C. for 15 minutes. Then, the single colony of probiotics cultured on the plate was cultured anaerobically at 37 ° C for 1 day in a long wool broth, and Bacillus subtilis and Bacillus coagulans were cultured at 43 ° C and 45 ° C, respectively, under aerobic conditions. did The culture medium was centrifuged at 4°C and 6,000 rpm to recover the supernatant, and concentrated 10 times using a concentrator. Finally, the supernatant was filtered using a filter having a size of 0.45 μm, and a sample for analysis was prepared.
[실시예 2] 비타민 A 정량분석[Example 2] Quantitative analysis of vitamin A
준비된 시료는 액체 크로마토그래피(Nanospace SI-2 3023, SHISEIDO, Tokyo, Japan)를 사용하여 분석하였다. 물질의 분리와 정량을 위해 CAPCELL PAK UG 120 S5 column (4.6 mm id x 250 mm)을 사용하였고, 이동상은 3차 증류수를 이동상 A, 90% acetonitrile + 10% 혼합액을 이동상 B로 사용하였다. 이동상은 0.8 ml/min의 유속으로 흘려주었다. 컬럼 온도는 37℃로 유지되었고, 20 ㎕의 시료를 주입하여 280 nm 파장의 UV 검출기를 이용하여 비타민 A1의 생성여부를 확인하였다. The prepared samples were analyzed using liquid chromatography (Nanospace SI-2 3023, SHISEIDO, Tokyo, Japan). A CAPCELL PAK UG 120 S5 column (4.6 mm id x 250 mm) was used for separation and quantification of substances, and tertiary distilled water was used as mobile phase A, and a mixture of 90% acetonitrile + 10% was used as mobile phase B. The mobile phase was flowed at a flow rate of 0.8 ml/min. The column temperature was maintained at 37° C., and 20 μl of the sample was injected to confirm the production of vitamin A1 using a UV detector with a wavelength of 280 nm.
비타민 A1의 표준물질 농도는 1mg/mL로 준비하였으며, 도 1에서 나타난 바와 같이 검량선의 신뢰도는 99.9% (R2=0.99948)이상임을 확인하였다. 이를 토대로 프로바이오틱스 상등액 내의 비타민 A1 생산량을 정량하여 도 2에 나타내었으며, 균주별로 비타민 A1 생성능을 비교하였다.The standard concentration of vitamin A1 was prepared at 1 mg/mL, and as shown in FIG. 1, it was confirmed that the reliability of the calibration curve was 99.9% (R2=0.99948) or higher. Based on this, vitamin A1 production in the probiotics supernatant was quantified and shown in FIG. 2, and vitamin A1 production ability was compared for each strain.
장모사배지에서 총 6종의 프로바이오틱스를 배양한 결과, 비피도박테리움 락티스 IDCC 4301에서 비타민 A1 생산능이 현저하게 우수한 것을 확인하였다. As a result of culturing a total of 6 types of probiotics in the long-haired medium, it was confirmed that Bifidobacterium lactis IDCC 4301 had a remarkably excellent vitamin A1 production ability.
Claims (4)
비피도박테리움 락티스 IDCC 4301[기탁번호: ATCC BAA-2848]을 포함하는 조성물.In the composition having a vitamin A producing function,
A composition comprising Bifidobacterium lactis IDCC 4301 [accession number: ATCC BAA-2848].
상기 비피도박테리움 락티스 IDCC 4301은 모유를 먹인 유아의 대변으로부터 분리된 조성물.According to claim 1,
The Bifidobacterium lactis IDCC 4301 is a composition isolated from feces of breast-fed infants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220122122A KR102523776B1 (en) | 2022-09-27 | 2022-09-27 | Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220122122A KR102523776B1 (en) | 2022-09-27 | 2022-09-27 | Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102523776B1 true KR102523776B1 (en) | 2023-04-21 |
Family
ID=86098721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220122122A KR102523776B1 (en) | 2022-09-27 | 2022-09-27 | Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102523776B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030061447A (en) * | 2000-12-19 | 2003-07-18 | 가부시키가이샤 야쿠루트 혼샤 | External skin preparations and process for producing the same |
KR20090094235A (en) | 2006-10-04 | 2009-09-04 | 꽁빠니 자베 다노느 | Culture method for favorising the production of k2 vitamin by lactic bacteria and applications thereof in the preparation of food products |
KR20150065170A (en) * | 2012-08-07 | 2015-06-12 | 탑제닉스, 인크. | Topical composition comprising transformed bacteria expressing a compound of interest |
US20190000124A1 (en) * | 2017-07-03 | 2019-01-03 | Oakbio, Inc. | Novel Microbial Biomass Based Feed Products |
KR102445708B1 (en) * | 2021-12-02 | 2022-09-23 | 일동바이오사이언스(주) | Composition for reducing body fat comprising Bifidobacterium lactis IDCC 4301 |
-
2022
- 2022-09-27 KR KR1020220122122A patent/KR102523776B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030061447A (en) * | 2000-12-19 | 2003-07-18 | 가부시키가이샤 야쿠루트 혼샤 | External skin preparations and process for producing the same |
KR20090094235A (en) | 2006-10-04 | 2009-09-04 | 꽁빠니 자베 다노느 | Culture method for favorising the production of k2 vitamin by lactic bacteria and applications thereof in the preparation of food products |
KR20150065170A (en) * | 2012-08-07 | 2015-06-12 | 탑제닉스, 인크. | Topical composition comprising transformed bacteria expressing a compound of interest |
US20190000124A1 (en) * | 2017-07-03 | 2019-01-03 | Oakbio, Inc. | Novel Microbial Biomass Based Feed Products |
KR102445708B1 (en) * | 2021-12-02 | 2022-09-23 | 일동바이오사이언스(주) | Composition for reducing body fat comprising Bifidobacterium lactis IDCC 4301 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2156751B1 (en) | Novel sweetener having sugar-like taste and production method and use of the same | |
CN113015810B (en) | Method for producing composition containing rare sugar, and composition containing rare sugar | |
CN102333459A (en) | The composition that comprises caffeoyl tartaric acid and/or its derivative | |
CN111194841A (en) | Functional spirulina protein peptide drink capable of improving immunity and improving sleep quality | |
CN102333455A (en) | Composition comprising chicoric acid and/or derivatives thereof | |
TWI430754B (en) | Process for producing γ-aminobutyric acid-rich material | |
CN102302059A (en) | Tartary buckwheat oligosaccharide yoghourt | |
KR102502110B1 (en) | Composition and health functional food containing Bacillus coagulans IDCC 1201 having vitamin B3 production ability | |
JP7177039B2 (en) | Phytochemical absorption enhancer | |
KR20220025680A (en) | Method for producing fermented balloon flower postbiotics with increased effective component content using lactic acid bacteria | |
KR102394733B1 (en) | Method for producing fermented spinach and fermented soybean with increased effective component content using lactic acid bacteria | |
KR102523776B1 (en) | Composition and health functional food containing Bifidobacterium lactis IDCC 4301 having vitamin A production ability | |
KR102538090B1 (en) | Food composition and health functional food containing Lactobacillus casei IDCC 3451 with proteolytic ability | |
KR102523775B1 (en) | Food composition and health functional food containing Lactobacillus plantarum IDCC 3501 with proteolytic ability | |
KR102549523B1 (en) | Food composition and health functional food containing Streptococcus thermophilus IDCC 2201 with vitamin B2 production ability | |
KR102423025B1 (en) | Food composition and health functional food containing Lactobacillus rhamnosus IDCC 3201 with proteolytic ability | |
KR102502721B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B6 production ability | |
KR102502109B1 (en) | Composition and health functional food containing Lacticaseibacillus rhamnosus IDCC 3201 having vitamin B1 production ability | |
KR102502112B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin C production ability | |
KR102536236B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B1 production ability | |
KR102502111B1 (en) | Composition and health functional food containing Lactococcus lactis IDCC 2301 having vitamin B9 production ability | |
KR102604295B1 (en) | Food composition comprising the fermentative products of Gryllus bimaculatus converted biologically and manufacturing method thereof | |
US20100197611A1 (en) | Alternative agent with vitamin d-like activity and an improving agent for intestinal function | |
CN112804886B (en) | Phytochemical absorption promoting composition | |
KR20180115103A (en) | Method of manufacturing spirulina having increased selenium and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |